AMIA suggests some fine-tuning for FDA's AI and machine learning regs

The informatics group says the feds should do more to protect against bad data and algorithm bias, and keep cybersecurity top of mind in its software-as-a-medical-device rules.

Source link

Related posts

How Do You Calculate Your Brand’s Conversational AI ROI? — Haptik Blog


Bayesian Optimisation with Gaussian Processes for Premise Selection. (arXiv:1909.09137v1 [cs.AI])


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy